Gianantonio Rosti, graduated in Medicine and Surgery at the University of Bologna in 1982, after which he became a fellow at the John Hopkins University Hospital (Baltimore, USA) until 1986. From 1988 to 1993 he was a Medical Assistant at the Institute of Hematology “Seràgnoli”, Bologna University, St Orsola Hospital and from 1994 to Nov 30,
2020. Since January 15, 2021 is Senior Scientist at the IRCCS/SIRHHC Scientific Institute for Research, Hospitalization and Health Care «Dino Amadori» – Meldola (FC), Italy.
As an expert in the conduction of clinical trials according to the GCP IHC (good clinical practice; International Committee on Harmonization), his specific scientific pursuits are numerous and include becoming a Scientific
Secretary (from 1992 to 2020) then member of the scientific board of the Italian Group For Adult Hematologic Malignancies [GIMEMA] Chronic Myeloid Leukemia Working Party [CML WP]). The GIMEMA CML WP is based on a collaborative effort of more than 100 Italian hematologic institutions (university hospitals and general hospitals)
performing clinical trials in CML.
Professor Rosti is also a member of the European Investigators on CML (EICML) and of the steering committee for the European Treatment and Outcome Study (EUTOS) registry, member of the ELN panel writing ELN recommendations (2013 and 2020 Eds), member of the scientific board of the Max Foundation and of the international CML foundation. His activity extends to the no-profit association AIL (italian association against
leukemia), being board member of the Bologna’s regional headquarter In addition to being an author or co-author to more than 300 papers and meetings abstracts.